Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma

BJU International

Volumn 93, Issue 3, 2004, Pages 291-296

  Joo, H J ^a   Oh, D K ^a   Kim, Y S ^a   Lee, K B ^a   Kim, S J ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Caveolin 1; Metastasis; Microvessel density; Prognosis; Renal cell carcinoma

Indexed keywords

ANTIBODY; CAVEOLIN 1; CD34 ANTIGEN; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ANGIOGENESIS; ANTIBODY SPECIFICITY; ARTICLE; ASSOCIATION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CAVEOLIN 1; CAVEOLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 1342288875     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04604.x     Document Type: Article

References (30)

1. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68: 673-82
2. Anderson RG. Caveolae. where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 1993; 90: 10909-13
3. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998; 273: 5419-22
4. Scherer PE, Lewis RY, Volonte D et al. Cell-type and tissue-specific expression of caveolin-2. Caveolin 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997; 272: 29337-46
5. Song KS, Scherer PE, Tang Z et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996; 271: 15160-5
6. Engelman JA, Zhang XL, Galbiati F et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 1998; 63: 1578-87
7. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999; 59: 5719-23
8. Kato K, Hida Y, Miyamoto M et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002; 94: 929-33
9. Griffoni C, Spisni E, Santi S, Riccio M, Guarnieri T, Tomasi V. Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 2000; 276: 756-61
10. Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem 2002; 277: 10661-8
11. Spisni E, Griffoni C, Santi S et al. Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res 2001; 266: 31-43
12. Massimino ML, Griffoni C, Spisni E, Toni M, Tomasi V. Involvement of caveolae and caveolae-like domains in signaling, cell survival and angiogenesis. Cell Signal 2002; 14: 93-8
13. Russo P. Renal cell carcinoma, presentation, staging, and surgical treatment. Semin Oncol 2000; 27: 160-76
14. Guinan P, Sobin LH, Algaba F et al. TNM staging of renal cell carcinoma: Workgroup, 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 992-3
15. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63
16. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-41
17. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-9
18. Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995; 92: 1381-5
19. Galbiati F, Volonte D, Engelman JA et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBOJ 1998; 17: 6633-48
20. Engelman JA, Zhang XL, Lisanti MP. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett 1998; 436: 403-10
21. Yang G, Truong LD, Timme TL et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 1998; 4: 1873-80
22. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001; 58: 811-4
23. Fine SW, Lisanti MP, Galbiati F, Li M. Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 2001; 115: 719-24
24. Davidson B, Nesland JM, Goldberg I et al. Caveolin-1 expression in advanced-stage ovarian carcinoma-a clinicopathologic study. Gynecol Oncol 2001; 81: 166-71
25. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998; 16: 1391-7
26. Wiechen K, Sers C, Agoulnik A et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001; 158: 833-9
27. Takehara K, Sakai H, Koga S, Kanetake H. Immunohistochemical expression of caveolin-1 as a marker for the biological potential of renal cell carcinoma. J Urol 2002; 167 (Suppl.): 132
28. Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology 1998; 51: 693-6
29. Paradis V, Ferlicot S, Ghannam E et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol 1999; 161: 1984-7
30. Rioux-Leclercq N, Epstein JI, Bansard JY et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 2001; 32: 1209-15